· Significant Win back of Pedia Market share through inspiring leadership, strategic initiatives and execution rigor with 25% Growth despite continued NIP Impact· Conceptualized & created globally recognized best practice model - Center of excellence for Adult Vaccination· Led the conversations on building the concept of Adult Vaccination with major corporate Hospitals (Apollo Grp, KIMS, AIG, Manipal) through engaging multiple stakeholder in the value chain (CXOs, Hospital Management, KOL, internal resources)· Instrumental in building Innovative Adult GTM to capitalize on the Corporate Hospital opportunity to build Adult Vaccines Ecosystem and integrate Vaccination as part of their treatment Protocols.· Lead Vaccines team to deliver organizational objectives despite Covid 19 disruption.· Led and motivated the Vaccines team to conduct 1200 digital CME, the highest in the country during the 2020 COVID pandemic which set the standard for excellence in Pfizer India· Drove business continuity to maintain customer contact and reach through quick adoption of digital platforms and building teams digital capability through extensive training· Developed robust tracking systems to maintain and track the progress of customers and competition prescription status and devise competitive strategy· Supported and Facilitated the Design and Launch of Critical Campaigns for Pedia and Adult (Radio- Kavya Campaign, Pneumo Hub, Pneumo care, Duty @50 ) in the absence of CBL and with CBMs onboarded· Designed the concept of COE (Centre of Excellence) to accelerate Adult Vaccination in Corporate hospitals· Developed I drive Platform along with Marketing and digital team to track customer behavior based on psychographic segmentation.· Worked with medical, marketing and other members of the XFT to build strong scientific communication, to ringfence pediatric business in light of heavy discounting from GSK in light low-priced Pneumococcal Vaccine launch by Serum with Made in India fan

· Successfully grew the Apollo business portfolio by 10% for Pfizer by leading organization wide initiatives to deliver 32 Cr (Hospital Business) in 2019 for KAM.· Launched specific Key Accounts products (NEXIUM injection) through innovative GTM partnering with distributors to deploy a contract field force to promote the product in targeted hospitals· Working with the Category Lead and conceptualize and implement a project to create a core group within the KAM team acting as the COE for the organization. This raised the image of the KAM team demonstrating to the India LT on their value as a strategic partner. This initiative was executed in Collaboration with Global & Regional teams. Aligned the Key account structure (Super KAM) in Pfizer to leverage on the external market consolidation (Hospital M&A) in Health care. Also changed the relationship model from key account to strategic partner. Through extensive stakeholder mapping by the team simplified the process and systems and built commercial policies to align to the market requirement to build Portfolio contracts & partnership programs with Key Accounts. Created KAM task force at the organizational level comprising (Medical, marketing, regulatory, finance, distribution, legal) to proactively address the issues in the hospitals and work with our partners to help them build their capabilities. Successfully developed partnership programs with key institutions coordinating with C-Suites (Apollo, Manipal, KIMS, Aster etc) e.g. Adult vaccination Clinics, AF clinics.

· Inspired my team to drive unprecedented medical engagements with Endocrinologists & Rheumatologists (~ 100 CMEs) through cross collaboration with the GCO, Compliance and Vaccines teams.· Partnered with Marketing, Regulatory, Public affairs, and Global team and KAM in preparing Brand plan and Launch strategy for Factor VIII launch in India-2018.· In collaboration with CBL and Category lead, my team successfully launched patented Pfizer research molecule tofacitinib which is a JAK inhibitor (Xeljanz) for treating Rheumatoid Arthritis and delivered 8 Cr in the first year of Launch-2018· Provided key strategic inputs as part of the Emerging market regional Advisory core team headed by Regional president, which helped to develop country specific initiatives. Due to changes in the external environment there was a need to change the access model in my BU. With my team I leveraged data and analytics to simplify pricing structure for important brands and significantly improve the access of these brands to more patients (Enbrel, Genotropin) in the Inflammation and rare disease space. In partnership with the KAM team, we accelerated the entry of newly launched brand in the Govt institutions such as ESI, CGHS and State governments along with support of medical, marketing and digital teams.

· Highest contribution of revenue sales to the organization and was and Top Performer in the country· Delivered Highest growth of 25% to the organization by accelerating the entry of products in Private and Govt Institutions· Closely working with BMS counterparts and alliance partners to facilitate the smooth transition from BMS to Pfizer for Solo promotion of Eliquis (Oral Anti-Coagulant) in India -2015· Played a key role in building the sales strategy, sales structure and deployment plan needed to drive Lyrica in India as a part of the newly created Global Innovative Product business in India.· Built new innovative GTM model to drive Champix adoption in key institutions through an innovative patient support model ( Adapted from Ottawa Model) to identify and help patients quit smoking, I helped my team organize multiple CMEs and screening camps in creating awareness on smoking cessation.· Partnered with CBL and Country Lead to successfully launch Eliquis in new indications like DVT treatment and the most important commercial opportunity which was in SPAF.· Initiated Corporate smoking cessation clinics with key hospital like Apollo to complement the efforts of the hospital in providing effective health care to the patients. Partnered with Tobacco control bodies to effectively provide information and awareness on the hazards of smoking.· Developed Successful Go to Market model for Champix by segregating trade and institutional business.

· Top Regional Business Manager for consecutive two year on 2013, 2014.· Was Instrumental in building the new formed region in South.

· The district delivered highest performance in the country for Consecutively 2 yrs in term of performance and growth.· Highest contributor in the term on revenue sales and growth for newly launched products.

· Designed training programs, write-ups specific to the needs of Districts and PSO’s with the objective of improving their “efficiency and effectiveness” in handling products and customers. 55-5· Initiated short and long-term training programs utilizing a database in the region for scheduling and tracking progress of participants to ensure that the learning objectives are being met while checking for compliance and completion of all requirements for assigned personnel.· Recognized for designing the challenging training programs initiated for the newly launched product for the treatment of neuropathic pain.· Developed in-house motivational newsletter capturing the performance highlights and success stories of the region promoting lateral learning.· Partnered with the sales team and rolled out District, PSO specific training programs to improve the sales performance and competency of the team Joined M/s Pfizer Limited in the year 1998, as Professional Service Officer.